However, in preliminary experiments, we observed that the standard immunization procedure with DNA coding for HER-2/neu in young transgenic mice delays but not abrogate the appearance of mammary tumours, since tumour masses progressively appeared after 40 weeks of age and more than 80% of mice were bearing tumour masses after 90 weeks of age. Here, ERBB2 is linked to breast cancer.